12 Health Care Stocks Moving In Thursday's Pre-Market Session

 

Gainers

  • Innate Pharma IPHA stock increased by 13.7% to $3.32 during Thursday's pre-market session. The market value of their outstanding shares is at $264.6 million.
  • Longeveron LGVN shares moved upwards by 13.29% to $8.01. The market value of their outstanding shares is at $167.0 million.
  • AnPac Bio-Medical Science ANPC stock moved upwards by 11.83% to $0.7. The market value of their outstanding shares is at $11.4 million.
  • ThermoGenesis Holdings THMO shares moved upwards by 11.66% to $0.69. The market value of their outstanding shares is at $8.2 million.
  • Chemomab Therapeutics CMMB stock moved upwards by 10.81% to $4.2. The market value of their outstanding shares is at $47.8 million. The company's, Q4 earnings came out yesterday.
  • Natera NTRA shares increased by 10.76% to $40.76. The company's market cap stands at $3.8 billion.

 

Losers

  • TherapeuticsMD TXMD shares declined by 20.2% to $0.32 during Thursday's pre-market session. The market value of their outstanding shares is at $135.6 million. As per the press release, Q4 earnings came out today.
  • I-MAB IMAB shares fell 18.57% to $17.5. The company's market cap stands at $1.3 billion.
  • TC BioPharm (Holdings) TCBP shares decreased by 16.67% to $1.15. The company's market cap stands at $32.2 million.
  • Sunshine Biopharma SBFM stock declined by 16.32% to $3.18. The company's market cap stands at $14.2 million.
  • Revelation Biosciences REVB stock fell 14.12% to $1.46. The company's market cap stands at $20.7 million.
  • Zai Lab ZLAB shares fell 12.87% to $34.0. The market value of their outstanding shares is at $3.2 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!